Tag: drug trials
Eli Lilly’s new obesity drug, retatrutide, passed its first late-stage diabetes trial.
In the ongoing saga of metabolic health, where chronic conditions like obesity and type 2 diabetes pose immense challenges globally, a whisper of a...



